Literature DB >> 10441607

Drug treatment of lipid disorders.

R H Knopp1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10441607     DOI： 10.1056/NEJM199908123410707

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  134 in total

Review 1.  Comparing HMG-CoA reductase inhibitors.

Authors:  Peter H Jones
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

Review 2.  Evidence-based management of dyslipidemias in women.

Authors:  John C LaRosa
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

3.  Effect of niacin on the choroidal circulation of patients with age related macular degeneration.

Authors:  T I Metelitsina; J E Grunwald; J C DuPont; G-S Ying
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

4.  The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study.

Authors:  Abhishek Vishnu; Matthew J Gurka; Mark D DeBoer
Journal:  Atherosclerosis       Date:  2015-09-21       Impact factor: 5.162

Review 5.  Distribution of cyclosporin in organ transplant recipients.

Authors:  Fatemeh Akhlaghi; Andrew K Trull
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 6.  Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering.

Authors:  Irina A Pikuleva
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-11       Impact factor: 4.481

7.  The Xbp1s/GalE axis links ER stress to postprandial hepatic metabolism.

Authors:  Yingfeng Deng; Zhao V Wang; Caroline Tao; Ningguo Gao; William L Holland; Anwarul Ferdous; Joyce J Repa; Guosheng Liang; Jin Ye; Mark A Lehrman; Joseph A Hill; Jay D Horton; Philipp E Scherer
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

Review 8.  New dimension of statin action on ApoB atherogenicity.

Authors:  M John Chapman; Muriel Caslake; Chris Packard; Fergus McTaggart
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

Review 9.  Therapy to reduce risk of coronary heart disease.

Authors:  Daniel J Rader
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

10.  Major lipids, apolipoproteins, and risk of vascular disease.

Authors:  Emanuele Di Angelantonio; Nadeem Sarwar; Philip Perry; Stephen Kaptoge; Kausik K Ray; Alexander Thompson; Angela M Wood; Sarah Lewington; Naveed Sattar; Chris J Packard; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-11-11       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.